Smith Thornton Advisors LLC Bristol Myers Squibb CO Transaction History
Smith Thornton Advisors LLC
- $152 Billion
- Q3 2024
A detailed history of Smith Thornton Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 3,911 shares of BMY stock, worth $216,200. This represents 0.13% of its overall portfolio holdings.
Number of Shares
3,911Holding current value
$216,200% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,457Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.77 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.06 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.13 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.26 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...